Skip to content

Per Oral Endoscopic Myotomy (POEM) for Esophagogastric Junction Outflow Obstruction (EGOO)

Per Oral Endoscopic Myotomy (POEM) for Esophagogastric Junction Outflow Obstruction (EGOO)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01942018
Enrollment
15
Registered
2013-09-13
Start date
2015-05-31
Completion date
2020-05-31
Last updated
2020-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagogastric Junction Outflow Obstruction

Keywords

esophagogastric junction outflow obstruction, EGOO, Per oral endoscopic myotomy, POEM, Gastroesophageal reflux disease, GERD

Brief summary

This research is being done to study an endoscopic procedure called POEM as a less invasive alternative to surgery in people with esophagogastric junction outlet obstruction (EGOO).

Detailed description

Patients with EGOO have difficulty swallowing and/or chest pain. Previously we were not able to distinguish this disease from achalasia. Achalasia is a disease which is characterized by a progressive difficulty with swallowing. It is caused by failure of relaxation of the lower esophageal sphincter (sphincter between esophagus and stomach) along with an essentially aperistaltic esophageal body. However, EGOO patients have abnormal lower esophageal sphincter relaxation with some preserved peristaltic activity. Because they have some peristalsis, these patients are not diagnosed with achalasia. Currently, a new diagnostic method, known as high-resolution manometry (HRM), can identify EGOO patients. EGOO patients usually do not respond well to medical treatment and surgery is required in most cases to reduce the pressure of lower esophageal sphincter muscles. This procedure is called Heller myotomy. Recently, a new endoscopic method for reducing lower esophageal sphincter pressure has been developed. This method, per-oral endoscopic myotomy (POEM) is now being performed clinically throughout the world, including Johns Hopkins Hospital. The technique utilizes a flexible endoscope to tunnel beneath the esophageal surface layer and cutting muscle fibers of the lower esophagus and upper stomach. POEM is an alternative to invasive surgery with fewer complications. POEM is performed safely at Johns Hopkins Hospital for achalasia patients. Outcomes of POEM have been excellent with greater than 90% positively responding to endoscopic myotomy. Patients with EGOO are being diagnosed more often due to increased use of HRM. They respond poorly to endoscopic therapies but well to surgical myotomy. POEM is the endoscopic equivalent to surgical intervention and represents a less invasive approach to treating these patients.

Interventions

PROCEDUREPOEM

Patients will receive Per oral endoscopic myotomy (POEM) for symptomatic gastroesophageal junction outflow obstruction (EGOO)

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Consecutive adult patients (18-70 years of age) with symptomatic dysphagia (dysphagia score ≥2) EGOO that is diagnosed by high resolution manometry. 2. Ability to give informed consent.

Exclusion criteria

1. Unable to give informed consent 2. Pregnant or breastfeeding women (all female patients if child-bearing age will undergo urine pregnancy testing prior to endoscopy) 3. Acute gastrointestinal bleeding 4. Coagulopathy defined by prothrombin time \< 50% of control; partial thromboplastin time (PTT) \> 50 sec, or international normalized ratio (INR) \> 1.5), on chronic anticoagulation, or platelet count \<75,000 5. Inability to tolerate sedated upper endoscopy due to cardio-pulmonary instability or other contraindication to endoscopy 6. Prior esophageal or gastric surgeries 7. Cirrhosis with portal hypertension, varices, and/or ascites 8. Active Esophagitis 9. Hiatal hernia larger than 2cm 10. Barrett's esophagus 11. Eosinophilic esophagitis 12. Esophageal stricture 13. Esophageal malignancy 14. Large esophageal diverticulum 15. Mechanical obstruction to esophageal outflow or infiltrative esophageal or gastric disorders. 16. Prior esophageal Botox injection

Design outcomes

Primary

MeasureTime frameDescription
Change in dysphagia severity2 and 6 monthsDysphagia will be measured by Dysphagia score and Eckhardt score at 2 and 6 months after the procedure (The Eckhardt score takes into consideration symptoms of dysphagia, chest pain, regurgitation and chest pain)

Secondary

MeasureTime frameDescription
Change in participants' quality of life2 and 6 monthsImprovement in patient's quality of life as reflected by Short Form-36 questionnaire at 2 and 6 months after the procedure
Complication rate2 yearsComplications include any of the following (full thickness perforations, unplanned mucosectomies, immediate and delayed bleeding).
Length of hospital stay2 years
Resolution in Esophago-gastric junction (EGJ) outflow obstruction by HRM performed 2 months after the procedure2 months
Post procedural Gastroesophageal reflux disease (GERD)2 monthsFrequency of post-procedural GERD as documented by either 24 hr ph/Impedence testing, 48 hr Bravo (performed at 2 months), or esophagogastroduodenoscopy (EGD) with evidence of esophagitis
Time to resume normal diet2 years
Procedural times2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026